Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...
On April 15, 2019, the New CTS Laboratory Information System has been successfully implemented in Po...